Table 1 Statistical analysis showing the effect of optimal nutraceutical combination on PCOS phenotypes in the lean PCOS population
PCOS characteristics | Clinical parameters | Lean PCOS control group* | Lean PCOS intervention group* | p-value |
|---|---|---|---|---|
Polycystic ovaries | Pre antral follicle (count) | 35.82 (2.67) | 21.75 (1.61) | < 0.0001 |
Anovulation | Cycle length (days) | 38.54 (0.96) | 35.04 (0.88) | < 0.0001 |
Oligomenorrhea | LH (IU/L) | 148.97 (10.12) | 107.73 (4.24) | < 0.0001 |
Infertility | Estradiol (pg/ml) | 299.83 (20.03) | 211.16 (13.86) | < 0.0001 |
Hirsutism | Testosterone (ng/dl) | 50.61 (2.54) | 40.76 (1.62) | < 0.0001 |
Infertility | AMH (ng/ml) | 5.17 (0.52) | 2.40 (0.31) | < 0.0001 |
Lean/Obese PCOS | Triglycerides (mg/dl) | 138.33 (6.58) | 112.83 (4.21) | < 0.0001 |